Compare MRNA & FUTU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | MRNA | FUTU |
|---|---|---|
| Founded | 2010 | 2011 |
| Country | United States | Hong Kong |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Investment Bankers/Brokers/Service |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 19.7B | 20.7B |
| IPO Year | 2018 | 2018 |
| Metric | MRNA | FUTU |
|---|---|---|
| Price | $49.11 | $140.20 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 12 | 4 |
| Target Price | $33.00 | ★ $217.75 |
| AVG Volume (30 Days) | ★ 7.1M | 1.4M |
| Earning Date | 04-30-2026 | 03-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 21.77 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $19,263,000,000.00 | N/A |
| Revenue This Year | $8.59 | $26.11 |
| Revenue Next Year | $16.72 | $11.75 |
| P/E Ratio | ★ N/A | $17.05 |
| Revenue Growth | ★ 4.29 | N/A |
| 52 Week Low | $22.28 | $70.60 |
| 52 Week High | $59.55 | $202.53 |
| Indicator | MRNA | FUTU |
|---|---|---|
| Relative Strength Index (RSI) | 45.17 | 46.17 |
| Support Level | $48.09 | $117.78 |
| Resistance Level | $54.94 | $155.54 |
| Average True Range (ATR) | 2.63 | 4.98 |
| MACD | -0.77 | 0.30 |
| Stochastic Oscillator | 17.40 | 44.04 |
Moderna is a commercial-stage biotech that was founded in 2010 and had its initial public offering in December 2018. The firm's mRNA technology was rapidly validated with its covid vaccine, which was authorized in the United States in December 2020. Moderna had 35 mRNA development candidates in clinical studies as of August 2025. Programs span a wide range of therapeutic areas, including infectious disease, oncology, cardiovascular disease, and rare genetic diseases.
Futu Holdings Ltd is an online broker providing one-stop online investing services. The company provides its services through its digital platform Futu NiuNiu, which includes market data, trading service, and news feed of Hong Kong, Mainland China, Singapore, and the United States equity markets. It generates its revenue in the form of brokerage commission and handling charge services, and interest income.